Table 2.
Observed indicators | r | 95%CI | p |
---|---|---|---|
Total-Chol | 0.233 | 0.177 to 0.288 | <0.001 |
Triglyceride | 0.181 | 0.124 to 0.237 | <0.001 |
HDL-Chol | 0.032 | −0.027 to 0.092 | 0.290 |
LDL-Chol | 0.195 | 0.138 to 0.251 | <0.001 |
ApoA1 | 0.044 | −0.015 to 0.103 | 0.141 |
ApoB | 0.111 | 0.053 to 0.169 | <0.001 |
Homocysteine | 0.106 | 0.048 to 0.164 | <0.001 |
Lip-PLA2 | 0.297 | 0.242 to 0.349 | <0.001 |
Note. Total-Chol: total cholesterol; HDL-Chol: high-density lipoprotein cholesterol; LDL-Chol: low-density lipoprotein cholesterol; ApoA1: apolipoprotein A1; ApoB: apolipoprotein B; Lip-PLA2: lipoprotein-associated phospholipase A2.
Among these observed atherosclerotic indicators, increased serum Lip-PLA2 level was most closely but only mildly correlated with increased urinary ACR levels (r = 0.297, p < 0.001).